The	O
c-rel	B-protein
protooncogene	I-protein
product	I-protein
represses	O
NF-kappa	B-protein
B	I-protein
p65	B-protein
-mediated	O
transcriptional	O
activation	O
of	O
the	O
long	O
terminal	O
repeat	O
of	O
type	O
1	O
human	O
immunodeficiency	O
virus	O
.	O

The	O
long	B-DNA
terminal	I-DNA
repeat	I-DNA
(	O
LTR	B-DNA
)	O
of	O
the	O
type	O
1	O
human	O
immunodeficiency	O
virus	O
(	O
HIV-1	O
)	O
and	O
the	O
5	B-DNA
'	I-DNA
regulatory	I-DNA
region	I-DNA
of	O
the	O
gene	O
encoding	O
the	O
interleukin	B-protein
2	I-protein
receptor	I-protein
alpha	I-protein
subunit	I-protein
(	O
IL-2R	B-protein
alpha	I-protein
)	O
share	O
functional	O
kappa	B-DNA
B	I-DNA
enhancer	I-DNA
elements	I-DNA
involved	O
in	O
the	O
regulation	O
of	O
these	O
inducible	O
transcription	O
units	O
during	O
T-cell	O
activation	O
.	O

These	O
kappa	B-DNA
B	I-DNA
enhancer	I-DNA
elements	I-DNA
are	O
recognized	O
by	O
a	O
structurally	O
related	O
family	O
of	O
interactive	O
proteins	O
that	O
includes	O
p50	B-protein
,	O
p65	B-protein
,	O
and	O
the	O
product	O
of	O
the	O
c-rel	B-DNA
protooncogene	I-DNA
(	O
c-Rel	B-protein
)	O
.	O

Recent	O
biochemical	O
studies	O
have	O
shown	O
that	O
p65	B-protein
and	O
p50	B-protein
form	O
the	O
prototypical	O
NF-kappa	B-protein
B	I-protein
complex	I-protein
,	O
which	O
is	O
rapidly	O
translocated	O
from	O
the	O
cytoplasm	O
to	O
the	O
nucleus	O
during	O
T-cell	O
activation	O
.	O

This	O
intracellular	O
signaling	O
complex	O
potently	O
stimulates	O
kappa	O
B-directed	O
transcription	O
from	O
either	O
the	O
HIV-1	B-DNA
LTR	I-DNA
or	O
the	O
IL-2R	B-DNA
alpha	I-DNA
promoter	I-DNA
via	O
the	O
strong	O
transactivation	O
domain	O
present	O
in	O
p65	B-protein
.	O

We	O
now	O
demonstrate	O
that	O
nuclear	O
expression	O
of	O
human	O
c-Rel	B-protein
,	O
which	O
is	O
induced	O
by	O
either	O
phorbol	O
ester	O
or	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
with	O
delayed	O
kinetics	O
relative	O
to	O
p65	B-protein
,	O
markedly	O
represses	O
p65	B-protein
-mediated	O
activation	O
of	O
these	O
transcription	O
units	O
.	O

These	O
inhibitory	O
effects	O
of	O
c-Rel	B-protein
correlate	O
with	O
its	O
DNA-binding	O
activity	O
but	O
not	O
with	O
its	O
ability	O
to	O
heterodimerize	O
with	O
p50	B-protein
,	O
suggesting	O
that	O
c-Rel	B-protein
inhibition	O
involves	O
competition	O
with	O
p50/p65	B-protein
for	O
occupancy	O
of	O
the	O
kappa	O
B	O
enhancer	O
element	O
.	O

Together	O
,	O
these	O
findings	O
suggest	O
that	O
one	O
function	O
of	O
c-Rel	B-protein
is	O
as	O
a	O
physiologic	O
repressor	O
of	O
the	O
HIV-1	B-DNA
LTR	I-DNA
and	O
IL-2R	B-protein
alpha	I-protein
promoters	O
,	O
serving	O
to	O
efficiently	O
counter	O
the	O
strong	O
transcriptional	O
activating	O
effects	O
of	O
p65	B-protein
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

90	NULL
,	NULL
pp	NULL
.	NULL

1023-1027	NULL
,	NULL
February	NULL
1993	NULL
Biochemistry	NULL
The	NULL
c-rel	NULL
protooncogene	NULL
product	NULL
represses	NULL
p65-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
type	NULL
1	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
STEFAN	NULL
DoERRE*	NULL
,	NULL
PRAKASH	NULL
SistTA	NULL
,	NULL
SHa0o-CONG	NULL
SUNT	NULL
,	NULL
DEAN	NULL
W	NULL
.	NULL

BALLARD	NULL
?	NULL

,	NULL
anp	NULL
WARNER	NULL
C.	NULL
GREENE	NULL
!	NULL

Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Box	NULL
3037	NULL
,	NULL
Duke	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
Durham	NULL
,	NULL
NC	NULL
27710	NULL
Communicated	NULL
by	NULL
Anthony	NULL
S.	NULL
Fauci	NULL
,	NULL
October	NULL
7	NULL
,	NULL
1992	NULL
(	NULL
received	NULL
for	NULL
review	NULL
August	NULL
13	NULL
,	NULL
1992	NULL
)	NULL
ABSTRACT	NULL
The	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
of	NULL
the	NULL
type	NULL
1	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV-1	NULL
)	NULL
and	NULL
the	NULL
5	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
interleukin	NULL
2	NULL
receptor	NULL
&	NULL
subunit	NULL
(	NULL
IL-2Ra	NULL
)	NULL
share	NULL
functional	NULL
xB	NULL
enhancer	NULL
elements	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
these	NULL
inducible	NULL
transcription	NULL
units	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

These	NULL
xB	NULL
enhancer	NULL
elements	NULL
are	NULL
recognized	NULL
by	NULL
a	NULL
structurally	NULL
related	NULL
family	NULL
of	NULL
interactive	NULL
proteins	NULL
that	NULL
includes	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
the	NULL
product	NULL
of	NULL
the	NULL
c-rel	NULL
protooncogene	NULL
(	NULL
c-Rel	NULL
)	NULL
.	NULL

Recent	NULL
biochemical	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
p65	NULL
and	NULL
p50	NULL
form	NULL
the	NULL
prototypical	NULL
NF-B	NULL
complex	NULL
,	NULL
which	NULL
is	NULL
rapidly	NULL
translocated	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

This	NULL
intracellular	NULL
signaling	NULL
complex	NULL
potently	NULL
stimulates	NULL
x	NULL
B-directed	NULL
transcription	NULL
from	NULL
either	NULL
the	NULL
HIV-1	NULL
LTR	NULL
or	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
via	NULL
the	NULL
strong	NULL
transactivation	NULL
domain	NULL
present	NULL
in	NULL
p65	NULL
.	NULL

We	NULL
now	NULL
demonstrate	NULL
that	NULL
nuclear	NULL
expression	NULL
of	NULL
human	NULL
c-Rel	NULL
,	NULL
which	NULL
is	NULL
induced	NULL
by	NULL
either	NULL
phorbol	NULL
ester	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
with	NULL
delayed	NULL
kinetics	NULL
relative	NULL
to	NULL
p65	NULL
,	NULL
markedly	NULL
represses	NULL
p6S-mediated	NULL
activation	NULL
of	NULL
these	NULL
transcription	NULL
units	NULL
.	NULL

These	NULL
inhibitory	NULL
effects	NULL
of	NULL
c-Rel	NULL
correlate	NULL
with	NULL
its	NULL
DNA-binding	NULL
activity	NULL
but	NULL
not	NULL
with	NULL
its	NULL
ability	NULL
to	NULL
heterodimerize	NULL
with	NULL
p50	NULL
,	NULL
suggesting	NULL
that	NULL
c-Rel	NULL
inhibition	NULL
involves	NULL
competition	NULL
with	NULL
p50/p65	NULL
for	NULL
occupancy	NULL
of	NULL
the	NULL
«	NULL
B	NULL
enhancer	NULL
element	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
one	NULL
function	NULL
of	NULL
c-Rel	NULL
is	NULL
as	NULL
a	NULL
physiologic	NULL
repressor	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
and	NULL
IL-2Ra	NULL
pro-moters	NULL
,	NULL
serving	NULL
to	NULL
efficiently	NULL
counter	NULL
the	NULL
strong	NULL
transcriptional	NULL
activating	NULL
effects	NULL
of	NULL
p65	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
(	NULL
1-3	NULL
)	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
genes	NULL
that	NULL
are	NULL
induced	NULL
during	NULL
T-cell	NULL
activation	NULL
,	NULL
including	NULL
those	NULL
encoding	NULL
the	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
receptor	NULL
(	NULL
IL-2Ra	NULL
)	NULL
(	NULL
4	NULL
)	NULL
and	NULL
the	NULL
type	NULL
1	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV-1	NULL
)	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
these	NULL
transcription	NULL
units	NULL
can	NULL
be	NULL
triggered	NULL
by	NULL
multiple	NULL
stimulants	NULL
,	NULL
including	NULL
phorbol	NULL
esters	NULL
(	NULL
2	NULL
,	NULL
4	NULL
)	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
the	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-I	NULL
)	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

These	NULL
same	NULL
activation	NULL
agents	NULL
also	NULL
induce	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
through	NULL
a	NULL
posttranslational	NULL
mechanism	NULL
involving	NULL
its	NULL
dissociation	NULL
from	NULL
a	NULL
cytoplasmic	NULL
inhibitor	NULL
(	NULL
s	NULL
)	NULL
termed	NULL
IkB	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

The	NULL
active	NULL
nuclear	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
heterodimeric	NULL
complex	NULL
composed	NULL
of	NULL
two	NULL
DNA-binding	NULL
subunits	NULL
,	NULL
termed	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
subunits	NULL
share	NULL
extensive	NULL
(	NULL
-300	NULL
amino	NULL
acids	NULL
)	NULL
N-terminal	NULL
sequence	NULL
homology	NULL
with	NULL
the	NULL
c-rel	NULL
protooncogene	NULL
product	NULL
(	NULL
c-Rel	NULL
)	NULL
(	NULL
refs	NULL
.	NULL

15-19	NULL
;	NULL
reviewed	NULL
in	NULL
ref	NULL
.	NULL

20	NULL
)	NULL
.	NULL

Like	NULL
p65	NULL
,	NULL
c-Rel	NULL
is	NULL
present	NULL
in	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
complexes	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
,	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
directly	NULL
to	NULL
the	NULL
«	NULL
kB	NULL
enhancer	NULL
(	NULL
22	NULL
)	NULL
,	NULL
and	NULL
can	NULL
associate	NULL
with	NULL
p50	NULL
(	NULL
23	NULL
)	NULL
.	NULL

However	NULL
,	NULL
while	NULL
p65	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
nucleus	NULL
within	NULL
minutes	NULL
following	NULL
T-cell	NULL
activation	NULL
with	NULL
phorbol	NULL
esters	NULL
,	NULL
the	NULL
induced	NULL
expression	NULL
of	NULL
nuclear	NULL
c-Rel	NULL
is	NULL
largely	NULL
delayed	NULL
for	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

1023	NULL
several	NULL
hours	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Recent	NULL
functional	NULL
studies	NULL
with	NULL
cloned	NULL
cDNAs	NULL
encoding	NULL
p50	NULL
and	NULL
p65	NULL
have	NULL
demonstrated	NULL
that	NULL
NF-kB	NULL
exerts	NULL
strong	NULL
activating	NULL
effects	NULL
on	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
and	NULL
IL-2Ra	NULL
promoter	NULL
principally	NULL
through	NULL
a	NULL
potent	NULL
transactivation	NULL
domain	NULL
located	NULL
in	NULL
the	NULL
C-terminal	NULL
portion	NULL
of	NULL
p65	NULL
(	NULL
24-26	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
c-Rel	NULL
also	NULL
appears	NULL
to	NULL
contain	NULL
a	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
(	NULL
27-30	NULL
)	NULL
;	NULL
however	NULL
,	NULL
this	NULL
domain	NULL
lacks	NULL
homology	NULL
with	NULL
the	NULL
corresponding	NULL
functional	NULL
domain	NULL
present	NULL
in	NULL
p65	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
p65	NULL
and	NULL
c-Rel	NULL
function	NULL
as	NULL
integral	NULL
components	NULL
of	NULL
a	NULL
counter-regulatory	NULL
network	NULL
of	NULL
Rel-related	NULL
transcription	NULL
factors	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Specifically	NULL
,	NULL
these	NULL
two	NULL
sequentially	NULL
induced	NULL
factors	NULL
display	NULL
striking	NULL
differences	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
activate	NULL
«	NULL
B	NULL
enhancer-mediated	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

Further	NULL
,	NULL
when	NULL
these	NULL
Rel	NULL
proteins	NULL
are	NULL
coexpressed	NULL
,	NULL
c-Rel	NULL
markedly	NULL
inhibits	NULL
p6S5-activated	NULL
transcription	NULL
from	NULL
either	NULL
the	NULL
HIV-1	NULL
LTR	NULL
or	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
.	NULL

Mutational	NULL
analyses	NULL
indicate	NULL
that	NULL
this	NULL
dominant	NULL
repressor	NULL
activity	NULL
of	NULL
c-Rel	NULL
involves	NULL
its	NULL
DNA-binding	NULL
function	NULL
rather	NULL
than	NULL
dimerization	NULL
properties	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
its	NULL
weak	NULL
transcriptional	NULL
activating	NULL
effects	NULL
,	NULL
c-Rel	NULL
also	NULL
has	NULL
the	NULL
capacity	NULL
to	NULL
act	NULL
as	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
nuclear	NULL
p65	NULL
function	NULL
.	NULL

As	NULL
such	NULL
,	NULL
competition	NULL
between	NULL
these	NULL
two	NULL
Rel	NULL
proteins	NULL
at	NULL
the	NULL
xB	NULL
enhancer	NULL
site	NULL
may	NULL
constitute	NULL
a	NULL
dynamic	NULL
mechanism	NULL
for	NULL
positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B-directed	NULL
transcription	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Expression	NULL
Vectors	NULL
.	NULL

All	NULL
re/-related	NULL
cDNAs	NULL
were	NULL
inserted	NULL
into	NULL
pCMV4	NULL
(	NULL
31	NULL
)	NULL
downstream	NULL
of	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
immediate-early	NULL
promoter	NULL
.	NULL

The	NULL
wild-type	NULL
human	NULL
c-Rel	NULL
(	NULL
hc-Rel	NULL
)	NULL
expression	NULL
vector	NULL
contained	NULL
a	NULL
full-length	NULL
cDNA	NULL
generated	NULL
by	NULL
RNA	NULL
amplification	NULL
(	NULL
19	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Nested	NULL
C-terminal	NULL
deletions	NULL
of	NULL
hc-Rel	NULL
were	NULL
produced	NULL
by	NULL
cloning	NULL
truncated	NULL
forms	NULL
of	NULL
this	NULL
cDNA	NULL
into	NULL
a	NULL
modified	NULL
pCMV4	NULL
vector	NULL
containing	NULL
a	NULL
universal	NULL
translational	NULL
terminator	NULL
.	NULL

Plasmids	NULL
denoted	NULL
c-Rel	NULL
(	NULL
1-298	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
1-289	NULL
)	NULL
were	NULL
created	NULL
by	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
to	NULL
introduce	NULL
a	NULL
translational	NULL
termination	NULL
codon	NULL
after	NULL
codons	NULL
298	NULL
and	NULL
289	NULL
,	NULL
respectively	NULL
.	NULL

Plasmids	NULL
expressing	NULL
the	NULL
N-terminal	NULL
deletion	NULL
series	NULL
c-Rel	NULL
(	NULL
33-587	NULL
)	NULL
,	NULL
c-Rel	NULL
(	NULL
125-587	NULL
)	NULL
,	NULL
c-Rel	NULL
(	NULL
184-587	NULL
)	NULL
,	NULL
and	NULL
c-Rel	NULL
(	NULL
291-587	NULL
)	NULL
were	NULL
constructed	NULL
by	NULL
amplification	NULL
with	NULL
oligonucleotide	NULL
primers	NULL
that	NULL
introduced	NULL
a	NULL
consensus	NULL
translation	NULL
initiation	NULL
site	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
human	NULL
p50	NULL
expression	NULL
plasmid	NULL
was	NULL
generated	NULL
by	NULL
inserting	NULL
into	NULL
Abbreviations	NULL
:	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
hc-Rel	NULL
,	NULL
human	NULL
c-Rel	NULL
;	NULL
HIV-1	NULL
,	NULL
type	NULL
1	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
;	NULL
HTLV-I	NULL
,	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
;	NULL
IL-2Ra	NULL
,	NULL
interleukin	NULL
2	NULL
receptor	NULL
a	NULL
subunit	NULL
;	NULL
LTR	NULL
,	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

*Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
Duke	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
Box	NULL
3010	NULL
,	NULL
Durham	NULL
,	NULL
NC	NULL
27710.	NULL
tPresent	NULL
address	NULL
:	NULL
Gladstone	NULL
Institute	NULL
of	NULL
Virology	NULL
and	NULL
Immunology	NULL
,	NULL
San	NULL
Francisco	NULL
General	NULL
Hospital	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
419100	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94141-9100.	NULL
address	NULL
:	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Vanderbilt	NULL
University	NULL
,	NULL
802	NULL
Light	NULL
Hall	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232-0295	NULL
.	NULL

1024	NULL
Biochemistry	NULL
:	NULL
Doerre	NULL
et	NULL
al	NULL
.	NULL

pCMV4	NULL
a	NULL
Rsa	NULL
1-truncated	NULL
form	NULL
of	NULL
the	NULL
full-length	NULL
KBF1	NULL
cDNA	NULL
(	NULL
16	NULL
)	NULL
which	NULL
encodes	NULL
an	NULL
~43-kDa	NULL
protein	NULL
(	NULL
aa	NULL
1-400	NULL
)	NULL
.	NULL

Expression	NULL
vectors	NULL
encoding	NULL
human	NULL
p65	NULL
(	NULL
18	NULL
,	NULL
26	NULL
)	NULL
,	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
HTLV-1	NULL
(	NULL
cTAX	NULL
)	NULL
(	NULL
33	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Tat	NULL
protein	NULL
of	NULL
HIV-1	NULL
(	NULL
cTAT	NULL
)	NULL
(	NULL
33	NULL
)	NULL
were	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

Transient	NULL
Transfections	NULL
and	NULL
Chloramphenicol	NULL
Acetyltrans-ferase	NULL
(	NULL
CAT	NULL
)	NULL
Assays	NULL
.	NULL

Human	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
effector	NULL
and	NULL
reporter	NULL
plasmids	NULL
by	NULL
using	NULL
DEAE-dextran	NULL
and	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Reporter	NULL
plasmids	NULL
contained	NULL
the	NULL
bacterial	NULL
CAT	NULL
gene	NULL
positioned	NULL
immediately	NULL
downstream	NULL
of	NULL
either	NULL
the	NULL
full-length	NULL
LTRs	NULL
of	NULL
HIV-1	NULL
or	NULL
HTLV-I	NULL
(	NULL
34	NULL
)	NULL
,	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
(	NULL
nt	NULL
-317	NULL
to	NULL
+109	NULL
)	NULL
(	NULL
35	NULL
)	NULL
,	NULL
or	NULL
the	NULL
HIV-1	NULL
«	NULL
B	NULL
enhancer	NULL
(	NULL
nt	NULL
-105	NULL
to	NULL
-79	NULL
)	NULL
inserted	NULL
immediately	NULL
upstream	NULL
of	NULL
a	NULL
basal	NULL
albumin	NULL
promoter	NULL
(	NULL
«	NULL
B-TATA-CAT	NULL
)	NULL
(	NULL
36	NULL
)	NULL
.	NULL

DNA-Protein	NULL
Interactions	NULL
.	NULL

Expression	NULL
vectors	NULL
encoding	NULL
wild-type	NULL
and	NULL
mutated	NULL
Rel	NULL
proteins	NULL
were	NULL
transfected	NULL
into	NULL
monkey	NULL
COS-7	NULL
cells	NULL
by	NULL
a	NULL
modified	NULL
DEAE-dextran	NULL
procedure	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Recipient	NULL
cells	NULL
were	NULL
metabolically	NULL
radiolabeled	NULL
with	NULL
[	NULL
}	NULL
SIcysteine	NULL
40-48	NULL
hr	NULL
after	NULL
transfection	NULL
(	NULL
37	NULL
)	NULL
and	NULL
lysed	NULL
in	NULL
a	NULL
low-stringency	NULL
buffer	NULL
containing	NULL
50	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7.0	NULL
)	NULL
,	NULL
250	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.5	NULL
mM	NULL
dithio-threitol	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
phenylmethanesulfonyl	NULL
fluoride	NULL
.	NULL

DNA-protein	NULL
crosslinking	NULL
reactions	NULL
(	NULL
20	NULL
Ll	NULL
)	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
``	NULL
P-labeled	NULL
palindromic	NULL
«	NULL
B	NULL
enhancer	NULL
probe	NULL
(	NULL
xB-pd	NULL
;	NULL
5'-CAACGGCAGGGGAATTCCCCTCTCCTT-3	NULL
'	NULL
)	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Radiolabeled	NULL
DNA-protein	NULL
adducts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
hc-Rel-specific	NULL
antiserum	NULL
and	NULL
analyzed	NULL
by	NULL
SDS/10	NULL
%	NULL
PAGE	NULL
.	NULL

Protein-Protein	NULL
Interactions	NULL
.	NULL

**S-labeled	NULL
proteins	NULL
were	NULL
synthesized	NULL
by	NULL
in	NULL
vitro	NULL
transcription/translation	NULL
using	NULL
rabbit	NULL
reticulocyte	NULL
lysates	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

C-terminal	NULL
deletions	NULL
of	NULL
he-Rel	NULL
were	NULL
translated	NULL
from	NULL
run-off	NULL
transcripts	NULL
synthesized	NULL
from	NULL
linearized	NULL
c-re/	NULL
cDNA	NULL
templates	NULL
cloned	NULL
into	NULL
pGEM-3	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
pGEM-3	NULL
expression	NULL
vectors	NULL
encoding	NULL
N-terminal	NULL
c-Rel	NULL
deletion	NULL
mutants	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Human	NULL
p50	NULL
was	NULL
expressed	NULL
from	NULL
a	NULL
pBluescript	NULL
(	NULL
Strat-agene	NULL
)	NULL
vector	NULL
containing	NULL
the	NULL
full-length	NULL
KBF1	NULL
cDNA	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
A.	NULL
Israel	NULL
;	NULL
ref	NULL
.	NULL

16	NULL
)	NULL
truncated	NULL
at	NULL
an	NULL
internal	NULL
Rsa	NULL
I	NULL
site	NULL
.	NULL

Protein-protein	NULL
interactions	NULL
were	NULL
assessed	NULL
by	NULL
immunoprecipitation	NULL
of	NULL
in	NULL
vitro	NULL
translation	NULL
mixtures	NULL
with	NULL
rabbit	NULL
anti-peptide	NULL
antibodies	NULL
specific	NULL
for	NULL
either	NULL
human	NULL
c-Rel	NULL
(	NULL
aa	NULL
132-150	NULL
or	NULL
573-587	NULL
)	NULL
,	NULL
or	NULL
p50	NULL
(	NULL
aa	NULL
1-21	NULL
)	NULL
.	NULL

All	NULL
immunoprecipitations	NULL
were	NULL
analyzed	NULL
by	NULL
SDS/10	NULL
%	NULL
PAGE	NULL
.	NULL

Immunoblot	NULL
Analyses	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
as	NULL
described	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Protein	NULL
samples	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
were	NULL
fractionated	NULL
under	NULL
reducing	NULL
conditions	NULL
by	NULL
SDS/7.5	NULL
%	NULL
PAGE	NULL
followed	NULL
by	NULL
electrotransfer	NULL
onto	NULL
nitrocellulose	NULL
mem-branes	NULL
.	NULL

Rel	NULL
polypeptides	NULL
were	NULL
detected	NULL
with	NULL
anti-peptide	NULL
antisera	NULL
raised	NULL
against	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
either	NULL
c-Rel	NULL
(	NULL
aa	NULL
573-587	NULL
)	NULL
or	NULL
p65	NULL
(	NULL
aa	NULL
529-551	NULL
)	NULL
,	NULL
using	NULL
enhanced	NULL
chemilumines-cence	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

RESULTS	NULL
Human	NULL
p65	NULL
and	NULL
c-Rel	NULL
Exhibit	NULL
Markedly	NULL
Different	NULL
«	NULL
B-Specific	NULL
Transcriptional	NULL
Activating	NULL
Properties	NULL
.	NULL

To	NULL
directly	NULL
compare	NULL
the	NULL
transactivation	NULL
potentials	NULL
of	NULL
p65	NULL
and	NULL
c-Rel	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
various	NULL
amounts	NULL
of	NULL
pCMV4	NULL
expression	NULL
plasmids	NULL
encoding	NULL
each	NULL
of	NULL
these	NULL
proteins	NULL
were	NULL
transiently	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
together	NULL
with	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
containing	NULL
either	NULL
the	NULL
full-length	NULL
HIV-1	NULL
LTR	NULL
(	NULL
HIV-1	NULL
LTR-CAT	NULL
;	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
or	NULL
the	NULL
HIV-1	NULL
«	NULL
B	NULL
enhancer	NULL
(	NULL
«	NULL
B-TATA-CAT	NULL
;	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
prior	NULL
reports	NULL
(	NULL
24-26	NULL
)	NULL
,	NULL
p65	NULL
markedly	NULL
induced	NULL
transcription	NULL
from	NULL
both	NULL
promoters	NULL
(	NULL
10-	NULL
to	NULL
100-fold	NULL
)	NULL
,	NULL
even	NULL
at	NULL
low	NULL
doses	NULL
(	NULL
1-2	NULL
ug	NULL
)	NULL
of	NULL
input	NULL
effector	NULL
plasmid	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cotransfection	NULL
with	NULL
even	NULL
higher	NULL
doses	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
of	NULL
the	NULL
c-Rel	NULL
expression	NULL
vector	NULL
failed	NULL
to	NULL
activate	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
and	NULL
stimulated	NULL
transcription	NULL
from	NULL
the	NULL
more	NULL
sensitive	NULL
«	NULL
B-TATA-CAT	NULL
template	NULL
at	NULL
least	NULL
an	NULL
order	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Relative	NULL
transcriptional	NULL
activities	NULL
of	NULL
p65	NULL
and	NULL
c-Rel	NULL
.	NULL

(	NULL
4	NULL
and	NULL
B	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
containing	NULL
either	NULL
the	NULL
full-length	NULL
HIV-1	NULL
LTR	NULL
(	NULL
HIV-1	NULL
LTR-CAT	NULL
)	NULL
(	NULL
4	NULL
)	NULL
or	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
(	NULL
«	NULL
B-TATA-CAT	NULL
)	NULL
(	NULL
B	NULL
)	NULL
and	NULL
various	NULL
amounts	NULL
of	NULL
a	NULL
c-Rel	NULL
(	NULL
a	NULL
)	NULL
or	NULL
p65	NULL
(	NULL
m	NULL
)	NULL
cDNA	NULL
expression	NULL
vector	NULL
.	NULL

Input	NULL
DNA	NULL
concentration	NULL
was	NULL
held	NULL
constant	NULL
in	NULL
all	NULL
transfections	NULL
by	NULL
inclusion	NULL
of	NULL
the	NULL
parental	NULL
pCMV4	NULL
expression	NULL
vector	NULL
lacking	NULL
a	NULL
cDNA	NULL
insert	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
determined	NULL
after	NULL
40	NULL
to	NULL
48	NULL
hr	NULL
and	NULL
are	NULL
presented	NULL
as	NULL
fold	NULL
induction	NULL
relative	NULL
to	NULL
the	NULL
basal	NULL
levels	NULL
measured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
either	NULL
effector	NULL
plasmid	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Expression	NULL
plasmids	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
encoding	NULL
wild-type	NULL
c-Rel	NULL
(	NULL
aa	NULL
1-587	NULL
)	NULL
or	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
truncated	NULL
at	NULL
aa	NULL
515	NULL
and	NULL
359	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
«	NULL
B-TATA-CAT	NULL
reporter	NULL
plasmid	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

Relative	NULL
CAT	NULL
activities	NULL
were	NULL
determined	NULL
as	NULL
indicated	NULL
above	NULL
.	NULL

(	NULL
D	NULL
and	NULL
E	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
HIV-1	NULL
LTR-CAT	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
and	NULL
either	NULL
a	NULL
mixture	NULL
of	NULL
p50	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
and	NULL
p65	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
expression	NULL
vectors	NULL
(	NULL
D	NULL
)	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
an	NULL
HTLV-I	NULL
Tax	NULL
expression	NULL
vector	NULL
(	NULL
E	NULL
)	NULL
along	NULL
with	NULL
various	NULL
doses	NULL
of	NULL
plasmids	NULL
encoding	NULL
wild-type	NULL
(	NULL
&	NULL
)	NULL
or	NULL
truncated	NULL
forms	NULL
(	NULL
aa	NULL
291-587	NULL
,	NULL
o	NULL
;	NULL
aa	NULL
1-515	NULL
,	NULL
m	NULL
)	NULL
of	NULL
c-Rel	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
determined	NULL
after	NULL
48	NULL
hr	NULL
of	NULL
culture	NULL
and	NULL
are	NULL
expressed	NULL
as	NULL
fold	NULL
induction	NULL
relative	NULL
to	NULL
basal	NULL
levels	NULL
measured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
added	NULL
effector	NULL
.	NULL

(	NULL
F	NULL
)	NULL
COS-7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
c-Rel	NULL
(	NULL
291-587	NULL
)	NULL
expression	NULL
plasmid	NULL
and	NULL
metabolically	NULL
radiolabeled	NULL
with	NULL
[	NULL
*S	NULL
}	NULL
cysteine	NULL
.	NULL

Recipient	NULL
cell	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
c-Rel-specific	NULL
anti-peptide	NULL
antiserum	NULL
(	NULL
aa	NULL
573-587	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
SDS/PAGE	NULL
.	NULL

Molecular	NULL
size	NULL
(	NULL
kDa	NULL
)	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

of	NULL
magnitude	NULL
less	NULL
than	NULL
that	NULL
observed	NULL
with	NULL
p65	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
C-terminal	NULL
72	NULL
aa	NULL
from	NULL
the	NULL
wild-type	NULL
c-Rel	NULL
protein	NULL
,	NULL
a	NULL
subregion	NULL
which	NULL
overlaps	NULL
sequences	NULL
previously	NULL
implicated	NULL
in	NULL
c-Rel-mediated	NULL
transactivation	NULL
(	NULL
27	NULL
)	NULL
,	NULL
virtually	NULL
abolished	NULL
these	NULL
modest	NULL
stimulatory	NULL
effects	NULL
on	NULL
the	NULL
HIV-1	NULL
«	NULL
kB	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Human	NULL
c-Rel	NULL
Represses	NULL
p6S5-Mediated	NULL
Transcription	NULL
.	NULL

The	NULL
distinct	NULL
transactivation	NULL
potentials	NULL
and	NULL
the	NULL
previously	NULL
described	NULL
delayed	NULL
nuclear	NULL
appearance	NULL
of	NULL
c-Rel	NULL
versus	NULL
p65	NULL
DNA-binding	NULL
activity	NULL
(	NULL
21	NULL
)	NULL
prompted	NULL
investigation	NULL
of	NULL
whether	NULL
c-Rel	NULL
might	NULL
negatively	NULL
regulate	NULL
p6S5-mediated	NULL
transcriptional	NULL
activation	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
immunoblotting	NULL
studies	NULL
of	NULL
nuclear	NULL
c-Rel	NULL
and	NULL
p65	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
either	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
clearly	NULL
showed	NULL
distinct	NULL
but	NULL
overlapping	NULL
induction	NULL
kinetics	NULL
for	NULL
these	NULL
two	NULL
Rel	NULL
proteins	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
potential	NULL
functional	NULL
consequences	NULL
of	NULL
the	NULL
simultaneous	NULL
expression	NULL
of	NULL
c-Rel	NULL
and	NULL
p65	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
HIV-1	NULL
LTR-CAT	NULL
reporter	NULL
,	NULL
a	NULL
mixture	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
expression	NULL
vectors	NULL
,	NULL
and	NULL
various	NULL
c-Rel	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
c-Rel	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50/p65	NULL
complex	NULL
activated	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
by	NULL
~9-fold	NULL
over	NULL
basal	NULL
levels	NULL
.	NULL

However	NULL
,	NULL
coexpression	NULL
of	NULL
c-Rel	NULL
in	NULL
these	NULL
cells	NULL
markedly	NULL
repressed	NULL
these	NULL
stimulatory	NULL
effects	NULL
in	NULL
a	NULL
Biochemistry	NULL
:	NULL
Doerre	NULL
et	NULL
al	NULL
.	NULL

A	NULL
PMA	NULL
c-Rel	NULL
-	NULL
»	NULL
we	NULL
c=	NULL
pés	NULL
-	NULL
»	NULL
Nives	NULL
:	NULL
Sevi	NULL
:	NULL
Sum	NULL
jo	NULL
(	NULL
s	NULL
,	NULL
p	NULL
2	NULL
”	NULL
Kc	NULL
?	NULL
'	NULL

a	NULL
0	NULL
)	NULL
“	NULL
02032	NULL
6	NULL
V	NULL
's	NULL
»	NULL
B	NULL
TNFa	NULL
c-Rel	NULL
-	NULL
»	NULL
wun	NULL
p6S	NULL
-	NULL
»	NULL
yes	NULL
:	NULL
®	NULL
«	NULL
\Q	NULL
NQ	NULL
NQ	NULL
NLA	NULL
\	NULL
0	NULL
$	NULL
.	NULL

&	NULL
2	NULL
,	NULL
9	NULL
,	NULL
c	NULL
0	NULL
7	NULL
A	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Time	NULL
course	NULL
for	NULL
induction	NULL
of	NULL
c-Rel	NULL
and	NULL
p65	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
,	NULL
50	NULL
ng/ml	NULL
)	NULL
(	NULL
4	NULL
)	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
(	NULL
TNFa	NULL
,	NULL
140	NULL
units/ml	NULL
)	NULL
(	NULL
B	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
(	NULL
0-24	NULL
hr	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
from	NULL
these	NULL
cells	NULL
were	NULL
fractionated	NULL
by	NULL
SDS/PAGE	NULL
and	NULL
subjected	NULL
to	NULL
immunoblot	NULL
analysis	NULL
with	NULL
c-Rel	NULL
and	NULL
p6S-specific	NULL
anti-peptide	NULL
antibodies	NULL
as	NULL
described	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

dose-dependent	NULL
manner	NULL
.	NULL

Similar	NULL
antagonistic	NULL
effects	NULL
were	NULL
observed	NULL
with	NULL
a	NULL
deletion	NULL
mutant	NULL
of	NULL
c-Rel	NULL
(	NULL
aa	NULL
1-515	NULL
)	NULL
lacking	NULL
the	NULL
C-terminal	NULL
subregion	NULL
required	NULL
for	NULL
its	NULL
weak	NULL
transactivation	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

However	NULL
,	NULL
selective	NULL
removal	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
from	NULL
the	NULL
wild-type	NULL
c-Rel	NULL
protein	NULL
yielded	NULL
an	NULL
efficiently	NULL
expressed	NULL
N-terminal	NULL
deletion	NULL
mutant	NULL
(	NULL
aa	NULL
291-587	NULL
;	NULL
Fig	NULL
.	NULL

1F	NULL
)	NULL
that	NULL
failed	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B-mediated	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

LD	NULL
)	NULL
.	NULL

These	NULL
inhibitory	NULL
effects	NULL
of	NULL
c-Rel	NULL
on	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
were	NULL
fully	NULL
recapitulated	NULL
in	NULL
independent	NULL
transfection	NULL
experiments	NULL
performed	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
encoding	NULL
the	NULL
HTLV-I	NULL
Tax	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1E	NULL
)	NULL
,	NULL
which	NULL
potently	NULL
activates	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
endogeneous	NULL
p50/p65	NULL
heterodimers	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
specificity	NULL
of	NULL
these	NULL
biological	NULL
effects	NULL
,	NULL
additional	NULL
functional	NULL
transfection	NULL
studies	NULL
were	NULL
performed	NULL
HTLV-I	NULL
LTR	NULL
80	NULL
|B	NULL
-317	NULL
IL-2Ro	NULL
601	NULL
a0	NULL
{	NULL
Relative	NULL
CAT	NULL
Activity	NULL
20	NULL
{	NULL
1	NULL
HIV-1	NULL
LTR	NULL
$	NULL
00	NULL
3	NULL
--	NULL
--	NULL
--	NULL
--	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
1025	NULL
using	NULL
CAT	NULL
reporter	NULL
constructs	NULL
driven	NULL
by	NULL
well-characterized	NULL
promoters	NULL
that	NULL
can	NULL
be	NULL
activated	NULL
in	NULL
either	NULL
a	NULL
«	NULL
B-dependent	NULL
or	NULL
a	NULL
«	NULL
B-independent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

HTLV-I	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
,	NULL
which	NULL
requires	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
events	NULL
(	NULL
8-10	NULL
)	NULL
,	NULL
was	NULL
inhibited	NULL
>	NULL
80	NULL
%	NULL
by	NULL
coexpression	NULL
with	NULL
either	NULL
wild-type	NULL
c-Rel	NULL
or	NULL
the	NULL
c-Rel	NULL
(	NULL
1-515	NULL
)	NULL
deletion	NULL
mutant	NULL
lacking	NULL
the	NULL
C-terminal	NULL
72	NULL
aa	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
,	NULL
which	NULL
proceeds	NULL
by	NULL
an	NULL
NF-xB-independent	NULL
mechanism	NULL
(	NULL
39-41	NULL
)	NULL
,	NULL
was	NULL
not	NULL
significantly	NULL
inhibited	NULL
by	NULL
either	NULL
c-Rel	NULL
or	NULL
c-Rel	NULL
(	NULL
1-515	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
xB-independent	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
by	NULL
the	NULL
HIV-1	NULL
Tat	NULL
protein	NULL
was	NULL
not	NULL
negatively	NULL
affected	NULL
by	NULL
coexpression	NULL
of	NULL
either	NULL
of	NULL
these	NULL
c-Rel	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Mutational	NULL
Analysis	NULL
of	NULL
c-Rel	NULL
Repressor	NULL
Function	NULL
.	NULL

To	NULL
define	NULL
more	NULL
precisely	NULL
which	NULL
peptide	NULL
sequences	NULL
within	NULL
c-Rel	NULL
were	NULL
required	NULL
for	NULL
its	NULL
repressor	NULL
activity	NULL
,	NULL
mutant	NULL
c-re/	NULL
expression	NULL
vectors	NULL
encoding	NULL
a	NULL
series	NULL
of	NULL
N-	NULL
or	NULL
C-terminally	NULL
truncated	NULL
forms	NULL
of	NULL
the	NULL
protein	NULL
were	NULL
prepared	NULL
.	NULL

These	NULL
mutants	NULL
were	NULL
first	NULL
transiently	NULL
expressed	NULL
in	NULL
Jurkat	NULL
human	NULL
T	NULL
cells	NULL
containing	NULL
the	NULL
HIV-1	NULL
LTR-CAT	NULL
construct	NULL
,	NULL
with	NULL
p65/pS50	NULL
as	NULL
the	NULL
activator	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
D	NULL
and	NULL
E	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
c-Rel	NULL
,	NULL
the	NULL
HIV-1	NULL
LTR	NULL
was	NULL
activated	NULL
4-	NULL
to	NULL
S-fold	NULL
by	NULL
the	NULL
cotransfected	NULL
p50	NULL
and	NULL
p65	NULL
expression	NULL
vectors	NULL
.	NULL

These	NULL
NF-	NULL
«	NULL
xB-mediated	NULL
stimulatory	NULL
effects	NULL
were	NULL
completely	NULL
inhibited	NULL
by	NULL
wild-type	NULL
c-Rel	NULL
(	NULL
aa	NULL
1-587	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
by	NULL
a	NULL
C-terminal	NULL
deletion	NULL
mutant	NULL
of	NULL
c-Rel	NULL
containing	NULL
aa	NULL
1-289	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

However	NULL
,	NULL
removal	NULL
of	NULL
an	NULL
additional	NULL
11	NULL
aa	NULL
from	NULL
this	NULL
c-Rel	NULL
mutant	NULL
significantly	NULL
impaired	NULL
its	NULL
ability	NULL
to	NULL
inhibit	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
response	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
C-terminal	NULL
boundary	NULL
of	NULL
the	NULL
involved	NULL
functional	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
lies	NULL
between	NULL
aa	NULL
289	NULL
and	NULL
278	NULL
.	NULL

In	NULL
reciprocal	NULL
experiments	NULL
with	NULL
a	NULL
series	NULL
of	NULL
N-terminal	NULL
deletion	NULL
mutants	NULL
(	NULL
Fig	NULL
.	NULL

removal	NULL
of	NULL
aa	NULL
1-32	NULL
from	NULL
the	NULL
full-length	NULL
c-Rel	NULL
protein	NULL
proved	NULL
sufficient	NULL
to	NULL
largely	NULL
disrupt	NULL
the	NULL
wild-type	NULL
inhibitory	NULL
phenotype	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
functional	NULL
studies	NULL
localized	NULL
the	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
involved	NULL
in	NULL
c-Rel-mediated	NULL
transcriptional	NULL
repression	NULL
between	NULL
aa	NULL
1	NULL
and	NULL
289	NULL
,	NULL
which	NULL
corresponds	NULL
with	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
the	NULL
inhibitory	NULL
effects	NULL
exerted	NULL
by	NULL
c-Rel	NULL
require	NULL
the	NULL
presence	NULL
of	NULL
sequences	NULL
within	NULL
its	NULL
Rel	NULL
homology	NULL
domain	NULL
suggested	NULL
that	NULL
the	NULL
mechanism	NULL
of	NULL
repression	NULL
might	NULL
involve	NULL
the	NULL
DNA-binding	NULL
properties	NULL
of	NULL
c-Rel	NULL
.	NULL

To	NULL
localize	NULL
the	NULL
c-Rel	NULL
DNA-binding	NULL
domain	NULL
,	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
overexpressing	NULL
these	NULL
various	NULL
deletion	NULL
mutants	NULL
were	NULL
subjected	NULL
to	NULL
$	NULL
to	NULL
ho	NULL
lete	NULL
tein	NULL
Heres	NULL
to	NULL
aces	NULL
Relative	NULL
CAT	NULL
Activity	NULL
o	NULL
\9°	NULL
FiG	NULL
.	NULL

3	NULL
.	NULL

-	NULL
(	NULL
A-C	NULL
)	NULL
Specificity	NULL
of	NULL
c-Rel-mediated	NULL
repression	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
containing	NULL
either	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
(	NULL
A	NULL
)	NULL
,	NULL
HTLV-I	NULL
LTR	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
HIV-1	NULL
LTR	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
(	NULL
C	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
(	NULL
basal	NULL
)	NULL
of	NULL
cDNA	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
indicated	NULL
proteins	NULL
(	NULL
Tax	NULL
,	NULL
1	NULL
ug	NULL
;	NULL
Tat	NULL
,	NULL
1	NULL
ug	NULL
;	NULL
c-Rel	NULL
,	NULL
5	NULL
ug	NULL
)	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
determined	NULL
after	NULL
40-48	NULL
hr	NULL
of	NULL
culture	NULL
and	NULL
are	NULL
presented	NULL
as	NULL
fold	NULL
induction	NULL
relative	NULL
to	NULL
basal	NULL
levels	NULL
measured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
effector	NULL
plasmids	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

(	NULL
D	NULL
and	NULL
E	NULL
)	NULL
Deletion	NULL
mapping	NULL
of	NULL
c-Rel	NULL
sequences	NULL
required	NULL
for	NULL
repression	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
HIV-1	NULL
LTR-CAT	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
and	NULL
a	NULL
mixture	NULL
of	NULL
p50	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
and	NULL
p65	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
expression	NULL
vectors	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
c-Rel	NULL
expression	NULL
vectors	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
encoding	NULL
the	NULL
indicated	NULL
C-terminal	NULL
(	NULL
D	NULL
)	NULL
or	NULL
N-terminal	NULL
(	NULL
E	NULL
)	NULL
deletion	NULL
mutants	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
determined	NULL
after	NULL
40-48	NULL
hr	NULL
of	NULL
culture	NULL
and	NULL
represent	NULL
mean	NULL
values	NULL
for	NULL
duplicate	NULL
experiments	NULL
(	NULL
<	NULL
20	NULL
%	NULL
variation	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
to	NULL
four	NULL
independent	NULL
transfection	NULL
assays	NULL
.	NULL

1026	NULL
Biochemistry	NULL
:	NULL
Doerre	NULL
et	NULL
al	NULL
.	NULL

UV-crosslinking	NULL
analysis	NULL
with	NULL
a	NULL
*°P-labeled	NULL
«	NULL
B	NULL
enhancer	NULL
probe	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
resultant	NULL
DNA-protein	NULL
adducts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
c-Rel-specific	NULL
antibodies	NULL
and	NULL
fractionated	NULL
by	NULL
SDS/PAGE	NULL
.	NULL

Extracts	NULL
from	NULL
vector-only-transfected	NULL
cells	NULL
had	NULL
virtually	NULL
no	NULL
xB	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
extracts	NULL
from	NULL
recipient	NULL
cells	NULL
overexpressing	NULL
wild-type	NULL
c-Rel	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
truncated	NULL
at	NULL
aa	NULL
515	NULL
,	NULL
359	NULL
,	NULL
307	NULL
,	NULL
296	NULL
,	NULL
or	NULL
289	NULL
supported	NULL
DNA	NULL
binding	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
smaller	NULL
crosslinked	NULL
adducts	NULL
(	NULL
lanes	NULL
3-7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
C-terminal	NULL
truncations	NULL
extending	NULL
to	NULL
either	NULL
aa	NULL
278	NULL
or	NULL
aa	NULL
263	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
completely	NULL
disrupted	NULL
this	NULL
DNA	NULL
binding	NULL
function	NULL
of	NULL
c-Rel	NULL
.	NULL

In	NULL
reciprocal	NULL
studies	NULL
,	NULL
N-terminal	NULL
deletion	NULL
mutants	NULL
truncated	NULL
at	NULL
aa	NULL
33	NULL
and	NULL
125	NULL
were	NULL
examined	NULL
,	NULL
and	NULL
both	NULL
were	NULL
found	NULL
to	NULL
lack	NULL
binding	NULL
to	NULL
the	NULL
xB	NULL
enhancer	NULL
probe	NULL
(	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

Control	NULL
immunoprecipitation	NULL
experiments	NULL
performed	NULL
with	NULL
these	NULL
two	NULL
N-terminal	NULL
deletion	NULL
mutants	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
C-terminal	NULL
mutants	NULL
truncated	NULL
at	NULL
residues	NULL
278	NULL
or	NULL
263	NULL
lacking	NULL
DNA-binding	NULL
activity	NULL
,	NULL
confirmed	NULL
that	NULL
each	NULL
of	NULL
these	NULL
proteins	NULL
was	NULL
efficiently	NULL
expressed	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
1-4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
c-Rel	NULL
subregion	NULL
required	NULL
for	NULL
«	NULL
B	NULL
enhancer	NULL
binding	NULL
maps	NULL
between	NULL
aa	NULL
1	NULL
and	NULL
289	NULL
and	NULL
appears	NULL
coincident	NULL
with	NULL
those	NULL
A	NULL
B	NULL
AcooH	NULL
___	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
s	NULL
9	NULL
ACOOH	NULL
ANHz	NULL
ANH	NULL
a	NULL
2	NULL
s	NULL
4	NULL
-	NULL
€	NULL
.	NULL
'	NULL

<	NULL
10	NULL
11	NULL
68.0-	NULL
68.0-	NULL
43.0	NULL
@	NULL
C24	NULL
43.0	NULL
anti	NULL
NF-kB	NULL
pSO	NULL
8	NULL
9	NULL
10	NULL
U	NULL
1	NULL
12	NULL
1	NULL
-r	NULL
I	NULL
I	NULL
29.0-	NULL
anti	NULL
NF-kB	NULL
p50	NULL
r	NULL
13	NULL
14	NULL
15	NULL
16	NULL
1	NULL
?	NULL

18	NULL
I	NULL
I	NULL
I	NULL
I	NULL
l.	NULL
@	NULL
.	NULL

©	NULL
-uzs	NULL
pso	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
c-Rel	NULL
sequences	NULL
required	NULL
for	NULL
repression	NULL
of	NULL
p65-induced	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
Rel	NULL
homology	NULL
domain	NULL
not	NULL
only	NULL
contains	NULL
a	NULL
DNA-binding	NULL
motif	NULL
but	NULL
also	NULL
sequences	NULL
that	NULL
mediate	NULL
oligomeriza-tion	NULL
with	NULL
other	NULL
Rel-related	NULL
proteins	NULL
(	NULL
20	NULL
)	NULL
,	NULL
including	NULL
the	NULL
formation	NULL
of	NULL
heterodimers	NULL
with	NULL
p50	NULL
(	NULL
15-18	NULL
,	NULL
23	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
c-Rel-mediated	NULL
repression	NULL
of	NULL
p65	NULL
activation	NULL
might	NULL
involve	NULL
competition	NULL
for	NULL
heterodimer	NULL
formation	NULL
with	NULL
p50	NULL
,	NULL
a	NULL
series	NULL
of	NULL
six	NULL
c-Rel	NULL
deletion	NULL
mutants	NULL
were	NULL
translated	NULL
in	NULL
vitro	NULL
by	NULL
using	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
p50	NULL
.	NULL

Immunoprecipitation	NULL
analyses	NULL
performed	NULL
with	NULL
S-labeled	NULL
lysates	NULL
confirmed	NULL
that	NULL
when	NULL
translated	NULL
alone	NULL
,	NULL
each	NULL
c-Rel	NULL
mutant	NULL
was	NULL
efficiently	NULL
expressed	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
1-6	NULL
)	NULL
and	NULL
lacked	NULL
reactivity	NULL
with	NULL
pS5Q-specific	NULL
antiserum	NULL
(	NULL
lanes	NULL
7-12	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
cotranslated	NULL
with	NULL
p50	NULL
,	NULL
the	NULL
1-359	NULL
and	NULL
1-278	NULL
C-terminal	NULL
truncations	NULL
and	NULL
the	NULL
33-587	NULL
and	NULL
125-587	NULL
N-terminal	NULL
truncations	NULL
of	NULL
c-Rel	NULL
formed	NULL
heteromeric	NULL
complexes	NULL
with	NULL
p50	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
their	NULL
coimmunoprecipita-tion	NULL
with	NULL
anti-p50	NULL
antiserum	NULL
(	NULL
lanes	NULL
13	NULL
,	NULL
14	NULL
,	NULL
16	NULL
,	NULL
and	NULL
17	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
1-263	NULL
C-terminal	NULL
deletion	NULL
mutant	NULL
and	NULL
the	NULL
184-587	NULL
N-terminal	NULL
deletion	NULL
mutant	NULL
failed	NULL
to	NULL
associate	NULL
with	NULL
p50	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
extreme	NULL
boundaries	NULL
for	NULL
the	NULL
heterodimer	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Deletion	NULL
mapping	NULL
of	NULL
the	NULL
c-Rel	NULL
DNA-binding	NULL
and	NULL
dimerization	NULL
domains	NULL
.	NULL

(	NULL
4	NULL
and	NULL
B	NULL
)	NULL
COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
either	NULL
wild-type	NULL
c-Rel	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
the	NULL
indicated	NULL
N-	NULL
and	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
and	NULL
were	NULL
metabolically	NULL
radiolabeled	NULL
after	NULL
48	NULL
hr	NULL
with	NULL
teine	NULL
.	NULL

Recipient	NULL
cell	NULL
lysates	NULL
(	NULL
1	NULL
ul	NULL
)	NULL
were	NULL
allowed	NULL
to	NULL
bind	NULL
and	NULL
then	NULL
crosslinked	NULL
to	NULL
a	NULL
-labeled	NULL
xB	NULL
enhancer	NULL
probe	NULL
.	NULL

Immunoprecipitation	NULL
was	NULL
then	NULL
performed	NULL
with	NULL
c-Rel-specific	NULL
antiserum	NULL
raised	NULL
against	NULL
aa	NULL
132-150	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Relative	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
c-Rel	NULL
deletion	NULL
mutants	NULL
defective	NULL
in	NULL
DNA	NULL
binding	NULL
(	NULL
lanes	NULL
8-11	NULL
of	NULL
A	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
immunoprecipitation	NULL
analysis	NULL
of	NULL
**S-labeled	NULL
lysates	NULL
(	NULL
100	NULL
ul	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
radiolabeled	NULL
DNA	NULL
(	NULL
B	NULL
,	NULL
lanes	NULL
1-4	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Run-off	NULL
transcripts	NULL
encoding	NULL
the	NULL
indicated	NULL
C-	NULL
and	NULL
N-terminal	NULL
deletion	NULL
mutants	NULL
of	NULL
c-Rel	NULL
were	NULL
translated	NULL
in	NULL
vitro	NULL
in	NULL
either	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
1-12	NULL
)	NULL
or	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
13-18	NULL
)	NULL
of	NULL
p50	NULL
transcripts	NULL
.	NULL

Programmed	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analysis	NULL
with	NULL
either	NULL
c-Rel-specific	NULL
(	NULL
lanes	NULL
1-6	NULL
)	NULL
or	NULL
pSQ-specific	NULL
(	NULL
lanes	NULL
7-18	NULL
)	NULL
antiserum	NULL
and	NULL
analyzed	NULL
by	NULL
SDS/PAGE	NULL
.	NULL

The	NULL
position	NULL
of	NULL
cotranslated	NULL
p50	NULL
revealed	NULL
in	NULL
lanes	NULL
13-18	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

Biochemistry	NULL
:	NULL
Doerre	NULL
et	NULL
al	NULL
.	NULL

ization	NULL
domain	NULL
of	NULL
c-Rel	NULL
are	NULL
located	NULL
between	NULL
aa	NULL
125	NULL
and	NULL
278	NULL
.	NULL

As	NULL
such	NULL
,	NULL
these	NULL
experiments	NULL
specifically	NULL
identify	NULL
a	NULL
class	NULL
of	NULL
c-Rel	NULL
mutants	NULL
,	NULL
including	NULL
c-Rel	NULL
(	NULL
1-278	NULL
)	NULL
(	NULL
lane	NULL
14	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
33-587	NULL
)	NULL
(	NULL
lane	NULL
16	NULL
)	NULL
,	NULL
which	NULL
retain	NULL
the	NULL
ability	NULL
to	NULL
dimerize	NULL
with	NULL
p50	NULL
yet	NULL
fail	NULL
to	NULL
repress	NULL
NF-	NULL
«	NULL
x	NULL
B-dependent	NULL
transcription	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
c-Rel	NULL
subregion	NULL
involved	NULL
in	NULL
heterodimer	NULL
formation	NULL
with	NULL
p50	NULL
appears	NULL
to	NULL
be	NULL
distinct	NULL
from	NULL
the	NULL
functional	NULL
domains	NULL
required	NULL
for	NULL
both	NULL
transcriptional	NULL
repression	NULL
and	NULL
«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
(	NULL
aa	NULL
1-289	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Prior	NULL
DNA-protein	NULL
crosslinking	NULL
studies	NULL
with	NULL
phorbol	NULL
ester-activated	NULL
Jurkat	NULL
cells	NULL
have	NULL
suggested	NULL
that	NULL
p65	NULL
(	NULL
early	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
late	NULL
)	NULL
are	NULL
expressed	NULL
with	NULL
distinct	NULL
but	NULL
overlapping	NULL
kinetics	NULL
during	NULL
the	NULL
course	NULL
of	NULL
T-cell	NULL
activation	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
prior	NULL
studies	NULL
,	NULL
immunoblotting	NULL
experiments	NULL
revealed	NULL
a	NULL
similar	NULL
delayed	NULL
pattern	NULL
of	NULL
nuclear	NULL
c-Rel	NULL
expression	NULL
relative	NULL
to	NULL
p65	NULL
following	NULL
treatment	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
findings	NULL
,	NULL
in	NULL
vivo	NULL
transient	NULL
transfection	NULL
studies	NULL
were	NULL
performed	NULL
to	NULL
directly	NULL
compare	NULL
the	NULL
transcriptional	NULL
activities	NULL
of	NULL
these	NULL
two	NULL
Rel	NULL
family	NULL
members	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
while	NULL
p65	NULL
is	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
both	NULL
the	NULL
HIV-1	NULL
LTR	NULL
and	NULL
a	NULL
synthetic	NULL
HIV-1	NULL
enhancer-CAT	NULL
construct	NULL
,	NULL
c-Rel	NULL
fails	NULL
to	NULL
activate	NULL
the	NULL
HIV-1	NULL
LTR	NULL
and	NULL
produces	NULL
at	NULL
least	NULL
10-fold	NULL
weaker	NULL
activating	NULL
effects	NULL
on	NULL
the	NULL
synthetic	NULL
«	NULL
xB	NULL
reporter	NULL
plasmid	NULL
.	NULL

Further	NULL
,	NULL
when	NULL
these	NULL
transcription	NULL
factors	NULL
are	NULL
coexpressed	NULL
,	NULL
c-Rel	NULL
markedly	NULL
represses	NULL
the	NULL
strong	NULL
activating	NULL
effects	NULL
of	NULL
p65	NULL
on	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

These	NULL
inhibitory	NULL
effects	NULL
of	NULL
c-Rel	NULL
are	NULL
not	NULL
dependent	NULL
on	NULL
its	NULL
unique	NULL
C-terminal	NULL
sequences	NULL
(	NULL
20	NULL
)	NULL
but	NULL
instead	NULL
are	NULL
correlated	NULL
with	NULL
sequences	NULL
in	NULL
the	NULL
Rel	NULL
homology	NULL
segment	NULL
that	NULL
mediate	NULL
DNA	NULL
binding	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
analyses	NULL
of	NULL
N-	NULL
and	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
of	NULL
c-Rel	NULL
clearly	NULL
segregated	NULL
repression	NULL
from	NULL
the	NULL
overlapping	NULL
but	NULL
distinct	NULL
dimerization	NULL
domain	NULL
within	NULL
c-Rel	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
c-Rel	NULL
represses	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcription	NULL
through	NULL
interference	NULL
with	NULL
p65	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
B	NULL
enhancer	NULL
.	NULL

These	NULL
findings	NULL
thus	NULL
highlight	NULL
the	NULL
apparently	NULL
opposing	NULL
functions	NULL
of	NULL
two	NULL
Rel	NULL
family	NULL
members	NULL
which	NULL
are	NULL
differentially	NULL
induced	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
repressive	NULL
properties	NULL
,	NULL
c-Rel	NULL
may	NULL
also	NULL
positively	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
select	NULL
cellular	NULL
genes	NULL
,	NULL
perhaps	NULL
including	NULL
those	NULL
whose	NULL
protein	NULL
products	NULL
are	NULL
required	NULL
in	NULL
the	NULL
later	NULL
phases	NULL
of	NULL
the	NULL
T-cell	NULL
activation	NULL
process	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
c-Rel	NULL
contains	NULL
a	NULL
relatively	NULL
weak	NULL
transcriptional	NULL
activation	NULL
domain	NULL
that	NULL
is	NULL
functional	NULL
in	NULL
several	NULL
cell	NULL
types	NULL
(	NULL
26-30	NULL
)	NULL
,	NULL
including	NULL
human	NULL
T	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
precise	NULL
factors	NULL
that	NULL
determine	NULL
whether	NULL
a	NULL
specific	NULL
xB	NULL
enhancer-containing	NULL
transcription	NULL
unit	NULL
will	NULL
be	NULL
positively	NULL
or	NULL
negatively	NULL
regulated	NULL
by	NULL
c-Rel	NULL
remain	NULL
unclear	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
subtle	NULL
sequence	NULL
variations	NULL
in	NULL
the	NULL
«	NULL
B	NULL
enhancer	NULL
motif	NULL
,	NULL
or	NULL
associated	NULL
promoter	NULL
elements	NULL
,	NULL
may	NULL
dictate	NULL
the	NULL
functional	NULL
consequences	NULL
of	NULL
c-Rel	NULL
binding	NULL
to	NULL
a	NULL
given	NULL
target	NULL
gene	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

As	NULL
well	NULL
,	NULL
the	NULL
cellular	NULL
context	NULL
in	NULL
which	NULL
c-Rel	NULL
acts	NULL
could	NULL
have	NULL
important	NULL
effects	NULL
on	NULL
its	NULL
ultimate	NULL
function	NULL
.	NULL

For	NULL
example	NULL
,	NULL
v-Rel	NULL
,	NULL
the	NULL
oncogenic	NULL
counterpart	NULL
of	NULL
c-Rel	NULL
,	NULL
exerts	NULL
strikingly	NULL
different	NULL
functional	NULL
effects	NULL
on	NULL
«	NULL
B-directed	NULL
transcription	NULL
,	NULL
dependent	NULL
upon	NULL
the	NULL
state	NULL
of	NULL
cellular	NULL
differentiation	NULL
(	NULL
44	NULL
)	NULL
.	NULL

We	NULL
thank	NULL
Alain	NULL
Israel	NULL
and	NULL
Craig	NULL
Rosen	NULL
for	NULL
full	NULL
length	NULL
NF-	NULL
«	NULL
B	NULL
cDNA	NULL
expression	NULL
plasmids	NULL
,	NULL
William	NULL
Walker	NULL
and	NULL
Jerry	NULL
Molitor	NULL
for	NULL
critical	NULL
discussion	NULL
,	NULL
and	NULL
Diane	NULL
Gearhart	NULL
for	NULL
manuscript	NULL
preparation	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
705-716	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
921-928	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
227-229	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
53	NULL
,	NULL
827-836	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
326	NULL
,	NULL
711-713	NULL
.	NULL

6	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
2331-2335.	NULL
appr	NULL
»	NULL
ia	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
1027	NULL
Osborn	NULL
,	NULL
L.	NULL
,	NULL
Kunkel	NULL
,	NULL
S.	NULL
&	NULL
Nabel	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
2336-2340	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Wano	NULL
,	NULL
Y.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
1652-1655	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
&	NULL
Nabel	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
333	NULL
,	NULL
776-778	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
,	NULL
Poteat	NULL
,	NULL
H.	NULL
,	NULL
Tan	NULL
,	NULL
T.-H.	NULL
,	NULL
Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Roeder	NULL
,	NULL
R.	NULL
,	NULL
Haseltine	NULL
,	NULL
W.	NULL
&	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
89-91	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
53	NULL
,	NULL
211-217	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
540-546	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
344	NULL
,	NULL
678-682	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
1689-1698	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1019-1029	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
961-969	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
,	NULL
Dillon	NULL
,	NULL
P.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
,	NULL
Maher	NULL
,	NULL
M.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
&	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
,	NULL
1490-1493	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
Mittereder	NULL
,	NULL
H.	NULL
&	NULL
Rice	NULL
,	NULL
N.	NULL
(	NULL
1989	NULL
)	NULL
Oncogene	NULL
4	NULL
,	NULL
935-942	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
841-843	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
10028-10032	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Sista	NULL
,	NULL
P.	NULL
,	NULL
Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Dixon	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Hannink	NULL
,	NULL
M.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
63	NULL
,	NULL
803-814	NULL
.	NULL

Logeat	NULL
,	NULL
F.	NULL
,	NULL
Israel	NULL
,	NULL
N.	NULL
,	NULL
Ten	NULL
,	NULL
R.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
&	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
1827-1832	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
&	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
3805-3817	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Narayanan	NULL
,	NULL
R.	NULL
,	NULL
Klement	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
&	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
444-454	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Dixon	NULL
,	NULL
E.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Stein	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
1875-1879	NULL
.	NULL

Bull	NULL
,	NULL
P.	NULL
,	NULL
Morley	NULL
,	NULL
K.	NULL
,	NULL
Hoekstra	NULL
,	NULL
M.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
&	NULL
Verma	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
5473-5485	NULL
.	NULL

Kamens	NULL
,	NULL
S.	NULL
,	NULL
Richardson	NULL
,	NULL
P.	NULL
,	NULL
Mosialos	NULL
,	NULL
G.	NULL
,	NULL
Brent	NULL
,	NULL
R.	NULL
&	NULL
Gilmore	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2840-2847	NULL
.	NULL

Richardson	NULL
,	NULL
P.	NULL
&	NULL
Gilmore	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

65	NULL
,	NULL
3122-3130	NULL
.	NULL

Inoue	NULL
,	NULL
J.-L.	NULL
,	NULL
Kerr	NULL
,	NULL
L.	NULL
,	NULL
Ransone	NULL
,	NULL
L.	NULL
,	NULL
Bengal	NULL
,	NULL
E.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
&	NULL
Verma	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
3715-3719	NULL
.	NULL

Andersson	NULL
,	NULL
S.	NULL
,	NULL
Davis	NULL
,	NULL
D.	NULL
,	NULL
Dahlback	NULL
,	NULL
H.	NULL
,	NULL
Jornvall	NULL
,	NULL
H.	NULL
&	NULL
Rus-sell	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
822-829	NULL
.	NULL

Kozak	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

196	NULL
,	NULL
947-950	NULL
.	NULL

Rimsky	NULL
,	NULL
L.	NULL
,	NULL
Hauber	NULL
,	NULL
J.	NULL
,	NULL
Dukovich	NULL
,	NULL
M.	NULL
,	NULL
Malim	NULL
,	NULL
M.	NULL
,	NULL
Langlois	NULL
,	NULL
A.	NULL
,	NULL
Cullen	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
335	NULL
,	NULL
738-740	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
,	NULL
Goh	NULL
,	NULL
W.	NULL
C.	NULL
&	NULL
Haseltine	NULL
,	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
228	NULL
,	NULL
1430-1434	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
,	NULL
4468-4472	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
,	NULL
Steffen	NULL
,	NULL
A.	NULL
,	NULL
Litfin	NULL
,	NULL
M.	NULL
&	NULL
Herrlich	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
5169-5181	NULL
.	NULL

Cullen	NULL
,	NULL
B.	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

152	NULL
,	NULL
684-704	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Miiller	NULL
,	NULL
M.	NULL
&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
.	NULL

Brady	NULL
,	NULL
J.	NULL
,	NULL
Jeang	NULL
,	NULL
K.-T.	NULL
,	NULL
Duvall	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Khoury	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

61	NULL
,	NULL
2175-2181	NULL
.	NULL

Paskalis	NULL
,	NULL
H.	NULL
,	NULL
Felber	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Paviakis	NULL
,	NULL
G.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83	NULL
,	NULL
6558-6562	NULL
.	NULL

Shimotohno	NULL
,	NULL
K.	NULL
,	NULL
Takano	NULL
,	NULL
M.	NULL
,	NULL
Teruuchi	NULL
,	NULL
T.	NULL
&	NULL
Miwa	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83	NULL
,	NULL
8112-8116	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
,	NULL
Schmid	NULL
,	NULL
R.	NULL
,	NULL
Duckett	NULL
,	NULL
C.	NULL
,	NULL
Leung	NULL
,	NULL
K.	NULL
,	NULL
Rice	NULL
,	NULL
N.	NULL
&	NULL
Nabel	NULL
,	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
1529-1533	NULL
.	NULL

Nakayama	NULL
,	NULL
K.	NULL
,	NULL
Shimizu	NULL
,	NULL
H.	NULL
,	NULL
Mitomo	NULL
,	NULL
K.	NULL
,	NULL
Watanabe	NULL
,	NULL
T.	NULL
,	NULL
Okamoto	NULL
,	NULL
S.-I	NULL
.	NULL

&	NULL
Yamamoto	NULL
,	NULL
K.-I	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
1736-1746	NULL
.	NULL

Walker	NULL
,	NULL
W.	NULL
,	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
Ganchi	NULL
,	NULL
P.	NULL
,	NULL
Hoffman	NULL
,	NULL
J.	NULL
,	NULL
Kaufman	NULL
,	NULL
P.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
,	NULL
Hannink	NULL
,	NULL
M.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

66	NULL
,	NULL
5018-5029	NULL
.	NULL

